Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

TULIP · Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility

HORIZONStatus: SIGNED1 January 202631 December 2029EU funding €1,803,600Call HORIZON-MSCA-2024-SE-01

Conception and pregnancy are both complex processes, with approximately 1 in 6 women worldwide experiencing infertility, often due to compromised uterine function, the organ designed solely for sustaining life. However, these dysfunctional uterine mechanisms remain not fully understood. Moreover, assisted reproduction technologies (ART) are employed to address infertility, with 5% of newborns in Europe conceived through ART. Nevertheless, the use of ART still results in low pregnancy success rates, with uterine dysfunction being a significant factor. This underscores the importance of the uterus in medical research, which has previously received little attention for its pivotal role in the journey towards motherhood.The TULIP consortium focuses on emerging topics, including the interplay between glycosylation and the microbiota within the uterus in relation to fertility. This interdisciplinary consortium comprises experts from six European countries, representing eight academic and four industry partners, and uniquely combines specialists in female reproductive medicine with researchers in glycobiology, microbiota studies, genomics, and data science. We aim to achieve a breakthrough in understanding the core biological aspects of conception, thereby fostering accurate and less invasive diagnostic methods that lead to more effective and personalised implementation of ART through pioneering tools designed to overcome poor reproductive outcomes.This breakthrough will be achieved by engaging 33 early-stage researchers in a collaborative interdisciplinary training and research programme. The programme seeks to emphasise scientific knowledge while fostering entrepreneurial and transferable skills over the 48-month project period. Collectively, these efforts enhance diagnostic and therapeutic tools to improve reproductive success in both natural and assisted conception while reinforcing inter-sectoral and interdisciplinary collaborative networks and the R&I capacity.

Consortium · 12 organisations

coordinator

KAROLINSKA INSTITUTET

SE · €240,480

associatedPartner

INSTITUTO AVANTIA DE FERTILIDAD SL

ES

participant

TARTU ULIKOOL

EE · €180,360

participant

UNIVERSIDAD DE GRANADA

ES · €180,360

participant

UNIVERSITEIT MAASTRICHT

NL · €210,420

participant

PANEPISTIMIO KRITIS

EL · €180,360

participant

NATIONAL UNIVERSITY OF IRELAND MAYNOOTH

IE · €180,360

participant

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA

ES · €60,120

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €120,240

participant

CELVIA CC AS

EE · €210,420

participant

IVI VALENCIA SL

ES · €120,240

participant

NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED

IE · €120,240

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.